250275-15-1

基本信息
顺式-2-BOC-六氢吡咯并[3,4-C]吡咯
内消旋-2-BOC-八氢吡咯[3,4-C]吡咯
cis-2-Boc-六氢吡咯并[3,4-c]吡咯
顺式-2-BOC-六氢吡咯并[3,4-C]吡咯 1G
cis-六氢吡咯并[3,4-c]吡咯-2-羧酸叔丁酯
顺式-叔丁基六氢吡咯并[3,4-C]吡咯-2(1H)-甲酸叔丁酯
(3AR,6AS)-叔丁基六氢吡咯并[3,4-C]吡咯-2(1H)-羧酸酯
2-BOC-HEXAHYDROPYRROLO[3,4-C]PYRROLE, CIS
cis-2-Boc-hexahydropyrrolo[3
-Boc-hexahydropyrrolo[3,4-c]pyrrole
3-Boc-3,7-diazabicyclo[3.3.0]octane
Cis-2-Boc-hexahydropyrrol-3,4-cpyrrole
cis-3-Boc-3,7-diazabicyclo[3.3.0]octane
CIS-2-BOC-HEXAHYDROPYRROLO[3,4-C]PYRROLE
2-boc-hexahydropyrrolo[3,4-c]pyrrole, cis
cis-3,7-Diazabicyclo[3.3.0]octane, N3-BOC protected
2-(tert-Butoxycarbonyl)hexahydropyrrolo[3,4-c]pyrrole
物理化学性质
制备方法

370879-56-4
![cis-2-Boc-六氢吡咯并[3,4-c]吡咯](/CAS/GIF/250275-15-1.gif)
250275-15-1
以顺式-5-苄基六氢吡咯并[3,4-c]吡咯-2(1H)-羧酸叔丁酯为原料合成顺式-叔丁基六氢吡咯并[3,4-c]吡咯-2(1H)-甲酸叔丁酯的一般步骤:向(3aR,6aS)-5-苄基六氢吡咯并[3,4-c]吡咯-2(1H)-羧酸叔丁酯(5g,16.5mmol)的甲醇(50mL)溶液中加入10% Pd(OH)2/C催化剂(0.5g)。将反应混合物置于氢气氛围(60psi)下,60℃搅拌过夜,随后冷却至室温。反应混合物经硅藻土过滤,滤液经减压浓缩,得到(3R,6aS)-六氢吡咯并[3,4-c]吡咯-2(1H)-羧酸叔丁酯,为无色油状物(2.3g,收率66%)。
参考文献:
[1] Patent: US2002/19388, 2002, A1
[2] Patent: WO2015/120049, 2015, A1. Location in patent: Page/Page column 139; 140
[3] Patent: WO2016/191172, 2016, A1. Location in patent: Page/Page column 86
[4] Patent: US2009/281118, 2009, A1. Location in patent: Page/Page column 10
[5] Journal of Medicinal Chemistry, 2009, vol. 52, # 14, p. 4126 - 4141
常见问题列表
cis-2-Boc-六氢吡咯并[3,4-c]吡咯是一种药物合成中间体,可由N-(甲氧基甲基)-N-三甲基甲硅烷基甲基)苄胺和N-苄基马来酰亚胺为原料,通过六步反应制备得到。